PetMed Express
PETS | NASDAQ
$0.90
-$0.04 (-4.28%)
At close: Nov 16, 2026, 4:00 PM ET
$0.90
$0.00 (-0.26%)
After-hours:
Nov 16, 2026, 7:30 PM ET
PetMed Express Company Profile
Company profile explainedCompany Profile
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Key Executives
| Name | Position |
|---|---|
| Jeffrey Allen Willard | Chief Executive Officer, Pres & Director |
| Andrew Parry | Chief Technology Officer |
| Caroline Conegliano | Chief Growth Officer |
| Doug Krulik | Chief Accounting Officer, Principal Acc. Off., Interim Principal Financial Officer & Treasurer |
| Jacqueline Smith | Vice President of People |
| Leslie C. G. Campbell | Strategic Advisor |
| Robert Lawsky | Corporate Secretary & General Counsel |
| Wendy Zalai | Corporate Controller & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 29, 2026 | 4 | Filing |
| Sep 29, 2026 | 3 | Filing |
| Sep 28, 2026 | S-8 | Filing |
| Sep 28, 2026 | S-8 | Filing |
| Sep 28, 2026 | 8-K | Current Report |
| Sep 21, 2026 | 4 | Filing |
| Sep 21, 2026 | 3 | Filing |
| Sep 21, 2026 | 8-K | Current Report |
| Sep 17, 2026 | 8-K | Current Report |
| Aug 13, 2026 | 4 | Filing |
PetMed Express
| Country | United States |
| IPO Date | Apr 26, 1999 |
| Industry | Specialty Retail |
| Sector | Consumer Cyclical |
| Employees | 189 |
| CEO | Jeffrey Allen Willard |
Contact Details
420 South Congress Avenue Delray Beach,
Florida 33445 United States
Stock Details
| Ticker Symbol | PETS |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001040130 |
| CUSIP Number | 716382106 |
| ISIN Number | US7163821066 |
| SIC Code | 5912 |
Add to Watchlist
Select watchlists to add or remove PETS